Publication Date:
2010
abstract:
The present invention relates to a novel process for the preparation of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxyamide, namely Rufinamide. Rufinamide is a known compound with anticonvulsive action, specifically used in combination with other antiepileptic medicaments for the treatment of Lennox-Gastaut syndrome, a rare form of epilepsy
Iris type:
6.1 Brevetto
Keywords:
RUFINAMIDE; ANTICONVULSANT; REGIOSELECTIVE PREPARATION
List of contributors: